BioRender 图标

PD-L1 / PD-L2 (monomer, short)

PD-L1 / PD-L2 (monomer, short) - Editable icon of a short PD-L1/PD-L2 monomer with extracellular IgV-like and IgC-like domains and cytoplasmic tail
[{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a80/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a80/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a7f/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a7f/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a7e/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a7e/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a7d/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a7d/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a7c/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a7c/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a7b/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a7b/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a7a/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a7a/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a79/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a79/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a78/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a78/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a77/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a77/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a76/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a76/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a75/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a75/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a74/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a74/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a73/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a73/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a72/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a72/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a71/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a71/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a70/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a70/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a6f/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a6f/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a6e/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a6e/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a6d/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a6d/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a6c/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a6c/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a6b/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a6b/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a6a/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a6a/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a69/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a69/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a68/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a68/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a67/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a67/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a66/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a66/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a65/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a65/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a64/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a64/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a63/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a63/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a62/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a62/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a61/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a61/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a60/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a60/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a5f/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a5f/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a5e/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a5e/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a5d/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a5d/63331232d8c4400021f6f82c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/633332a4f544890021309a5c/63331232d8c4400021f6f82c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/633332a4f544890021309a5c/63331232d8c4400021f6f82c.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
PD-L1,PD-L2,PDL1,PDL2,programmed death-ligand,cluster of differentiation,B7 homolog 1,programmed death-ligand 1,cluster of differentiation 274,programmed cell death-ligand 2,CD274,B7-H,B7H1,PD-L1,PDCD1L1,PCCD1LG1,PDL1,PDCD1LG2,B7DC,CD273,PDCD1L2,PDL2,bA574F11.2,short,monomer,proj-shortreceptor-icons-22q1,PD-L1,PD-L2,PDL1,PDL2
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

PD-L1 / PD-L2 (monomer, short) icon JPEG

PD-L1 / PD-L2 (monomer, short) icon PNG

PD-L1 / PD-L2 (monomer, short) icon SVG

PD-L1 / PD-L2 (monomer, short) icon GIF

BioRender 图标常见问题解答

How are scientists using the PD-L1 / PD-L2 (monomer, short) icon in their work?

BioRender users often use the PD-L1 / PD-L2 (monomer, short) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Proteins.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the PD-L1 / PD-L2 (monomer, short) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the PD-L1 / PD-L2 (monomer, short) icon customizable in BioRender?

Most icons in BioRender, including the PD-L1 / PD-L2 (monomer, short) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the PD-L1 / PD-L2 (monomer, short) icon for publication or presentations?

Yes, figures containing the PD-L1 / PD-L2 (monomer, short) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the PD-L1 / PD-L2 (monomer, short) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the PD-L1 / PD-L2 (monomer, short) icon — especially those focused on Proteins. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this PD-L1 / PD-L2 (monomer, short) icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon